Objectives To compare mesoscopic epi-fluorescence tomography (MEFT) and EPRI-illumination reflectance imaging (EPRI) for quantitative tumour size assessment in mice. Methods Tumour xenografts of green/red fluorescent protein (GFP/RFP)-expressing colon cancer cells were measured using MEFT, EPRI, ultrasound (US) and micro computed tomography (μCT) at day 14 post-injection (n06). Results from MEFT and EPRI were correlated with each other and with US and μCT (reference methods). Tumour volumes were measured ex vivo by GFP and RFP fluorescence imaging on cryoslices and compared with the in vivo measurements. Results High correlation and congruency were observed between MEFT, US and μCT (MEFT/US: GFP: r 2 00.96; 
Introduction
The precise localization and demarcation of a lesion is crucial for tumour staging, interventions and therapy control and can be achieved by non-invasive imaging, e.g. magnetic resonance imaging (MRI), μCT and ultrasound [1] [2] [3] . In preclinical research, the use of fluorescent proteins has been shown to be highly useful, because it allows imaging of cancer progression in mice from macro to subcellular level [4] .
We recently compared MRI, μCT, EPRI-illumination reflectance imaging (EPRI) and caliper measurements for tumour growth assessment of green/red fluorescent protein (GFP/RFP)-expressing subcutaneous colon xenografts (HCT-116-GFP-RFP) in nude mice over 16 days [5] . MRI sensitively detected tumours and precisely determined their size. μCT was also very accurate in volume determination of larger tumours. Although EPRI was as sensitive as MRI, it overestimated the tumour size and fluorescence intensity correlated better with tumour volume measured by MRI than fluorescence area.
Optical reflectance imaging is limited by the depth dependency of the signals owing to absorption and multiple scattering of the photons in the tissue [6] . These can be overcome by tomographic imaging that allows the threedimensional (3D) reconstruction of the fluorescent signals and thus a more precise volume measurement of tumours expressing fluorescent proteins.
Contrary to most tomographic approaches that are based on transillumination, the newly established mesoscopic epifluorescence tomography (MEFT) enables the 3D reconstruction and quantification of the fluorescence distribution in the reflectance geometry. MEFT could image a tube filled with a GFP-like fluorescent dye even at a depth of 1 cm in a highly absorbing and scattering medium and accurately determined the diameter of the tube at depths up to 700 μm [7] . In addition, MEFT accurately determined the diameter and spatial position of a fluorescent phantom implanted ex vivo at 1 cm depth and in mice at varying depths as great as 2,200 μm [8] .
In the present study, we compared EPRI and 3D reconstructed MEFT with ultrasound (US) and μCT for tumour volume determination in subcutaneous human colon cancer xenografts (HCT-116-GFP-RFP) in nude mice [9] [10] [11] .
Materials and methods

Cell line
The doubly transfected human colon cancer cell line HCT-116-GFP-RFP, which stably expresses GFP in the nucleus and RFP in the cytoplasm [9, 10] , was cultivated in RPMI 1560 medium (Gibco®, Invitrogen GmbH, Darmstadt, Germany) containing 10 % fetal bovine serum (Gibco®), 1 % penicillin/streptomycin (Gibco®) and 400 μg/mL Genetecin (Gibco®).
Tumour model
A total of 2×10 6 HCT-116-GFP-RFP cells were injected subcutaneously into the right flank of six 6-to 8-week-old female CD-1 nude mice (Charles River, Sulzfeld, Germany). A total of six mice were included in the study. Fourteen days after injection, the tumour sizes were determined by US and μCT. For MEFT measurements, the mice were carefully stabilized in an imaging chamber without restricting their breathing. For all non-invasive imaging techniques, the animals were anaesthetized by inhaling a mixture of isoflurane (1.5 %) and O 2 . After the MEFT measurements, the animals were immediately euthanized in the imaging chamber by an overdose of ketamine and xylazine and prepared for ex vivo cryotome analysis.
Imaging modalities and protocols
Epi-fluorescence imaging and mesoscopic epi-fluorescence tomography (MEFT)
The 3D reconstruction of the epi-fluorescence was done in a MEFT system (Fig. 1) . The MEFT system measures fluorescence distribution using a laser point source for illumination and a charge-coupled device (CCD) camera for detection [7] . For excitation, a diode laser-pumped allsolid-state laser with an output power of 5 mW at a wavelength of λ0473 nm for GFP and λ0532 nm for RFP was utilized (CNI, Changchun, China). The collimated laser beam was reflected at a dichroic mirror (Thorlabs, Newton, NJ, USA) and scanned over the subcutaneous (s.c.) tumour using x/z-moving stages (Standa, Vilnius, Lithuania) with Fig. 1 Set-up of the MEFT system. A diode laser-pumped all-solid-state laser with a wavelength of λ0473 nm for GFP and λ0532 nm for RFP was used. The collimated laser beam was reflected at a dichroic mirror and scanned over the s.c. tumour by using x/z-moving stages. The epifluorescence was transmitted back through the dichroic mirror and a longpass colour filter and collected by a 12-bit cooled CCD camera 10×10 source positions. Imaging data were acquired with automatically optimized exposure times for GFP and RFP [8] . The epi-fluorescence was transmitted back through the dichroic mirror and a long-pass colour filter (Schneider Optik, Bad Kreuznach, Germany). For sensitive photon detection, a 12-bit cooled CCD camera with a frame rate of 51.5 Hz (Hamamatsu Photonics, Hamamatsu City, Japan) and an installed objective with a focal distance of 35 mm (Carl Zeiss, Oberkochen, Germany) were used. The total scan time per mouse was approximately 9 min. To acquire planar epi-fluorescence images (EPRI data), an expanded laser beam was used for image acquisition. Beam widening was achieved using a light diffuser (Luminit, Torrance, CA, USA) and led to a spot full width at half maximum (FWHM) of 24.7 mm. Fluorescence measurements of GFP and RFP were normalized to their maximal levels by the function of FWHM in order to acquire the width and length of the tumour (EPRI data). For 3D reconstruction (MEFT data), background levels in the region of interest were subtracted from the EPRI raw data. The data were reconstructed in 3D using the function of FWHM and reconstruction algorithms of fluorescence distributions as described [7] .
Reference imaging methods (micro computed tomography and ultrasound)
μCT was performed using a dual source μCT system Tomoscope Duo (CT Imaging GmbH, Erlangen, Germany). For CT data acquisition, both tubes ran at energies of 40 kV and 1 mA, resulting in an exposure dose of 344 mGy per data acquisition. Each flat panel detector acquired 720 projections at 5 frames per seconds (fps) with 1,032×1,012 pixels and a pixel size of 50 μm 2 . The CT data acquisition took 90 s. A Feldkamp algorithm with soft reconstruction kernel (T10) and isotropic voxel sizes of 70 μm was used for image reconstruction. The field of view was 42 mm×35 mm× 30.8 mm.
US
Tumour volumes were measured in vivo using a highresolution US system, Vevo™ 770 (VisualSonics Inc, Toronto, Ontario, Canada). The anaesthetized mice were placed on a heating pad (37°C). A 3D ultrasound scan was performed using a 25-MHz transducer. The field of view was 16 mm×16 mm with step sizes of 0.102 mm. Tumour volume was determined by summation of the in-plane segmented regions and multiplying this quantity by the interslice spacing using the Vevo ultrasound software (VisualSonics Vevo™ 770). Ultrasound was used as a reference method owing to its known high accuracy [12] .
Ex vivo cryotome analysis
In vivo EPRI data and 3D MEFT data were compared to fluorescence imaging of ex vivo cryoslicer sections [13] . After MEFT measurements, the animals were killed by an overdose of ketamine (800 mg/kg, Ketalar, Parke-Davis) and xylazine (250 mg/kg, Rompun, Bayer) in the imaging chamber without changing the position of the animals. Subsequently, the mice were frozen at −20°C within the imaging chamber to maintain the bodies in the imaged position. The tumour was embedded in optimal cutting temperature compound (OCT) and frozen at −80°C. Finally, the tumour was cut in slices of 250-μm sections. Bright light images as well as fluorescence images at a wavelength of λ0480 nm for GFP and λ0545 nm for RFP were acquired for each slice.
Measurement and calculation of tumour volume
Assuming the tumour to have an ellipsoid shape, tumour volume was calculated by the following formulae:
where a is the tumour length, b the tumour width and c the tumour depth.
For EPRI, tumour length and width were determined by the FWHM of the diffuse signals along the x-and y-axes.
Statistical analysis
In vivo data of EPRI and MEFT were correlated with data obtained by the two reference methods, US and μCT. The Pearson's correlation coefficients (r) and the significance of correlation (P value) were determined. In vivo MEFT measurements were correlated with ex vivo fluorescence imaging data from cryoslices. In addition, the maximum error in detecting the tumour size and depth was calculated for all modalities. A paired Student's t test and Bonferroni correction were applied to analyse the differences in the mean tumour volume. A P value less than 0.05 was considered as significantly different.
Results
Reconstruction of fluorescence distribution in vivo using MEFT
In vivo fluorescence imaging (EPRI and MEFT) was performed using the MEFT system. For 3D reconstruction, the reflectance images were processed by MEFT reconstruction algorithms and the fluorescent tumour was subsequently segmented. Figure 2 shows the reconstructed fluorescence distribution of the tumour in the RFP channel in the xy direction (left) as well as the xz direction (right).
Comparison of the reference imaging methods (μCT and US)
A sharper demarcation of the tumour was achieved by US compared with μCT owing to the better soft tissue contrast with US (Fig. 3a, b) . Nevertheless, a high correlation (r 2 00.88, P<0.05) and congruency (data not shown) were observed between μCT and US data.
Comparison of EPRI and reconstructed MEFT with US and μCT for tumour visualization in vivo EPRI of the GFP-and RFP-expressing tumours showed diffuse fluorescence signals with imprecise borders, covering a larger area compared with the tumour area depicted by US and μCT (Fig. 3c, d ). 3D reconstruction by MEFT resulted in a precisely demarcated tumour, as demonstrated by the front and side images of GFP and RFP fluorescence (Fig. 3e-h ).
Correlation of EPRI and reconstructed MEFT with US and μCT for tumour volume measurements EPRI and MEFT tumour volume determinations were correlated with US and μCT (Fig. 4a, b) . MEFT strongly correlated with US (GFP: r 2 00.96; RFP: r 2 00.97; both P <0.05) and μCT (GFP: r 2 00.93; RFP: r 2 00.90; both P<0.05). MEFT data were highly congruent with the data of both reference modalities, as the data pairs almost aligned at the bisectrix at 45° (Fig. 4a, b) . EPRI showed a high correlation with US (GFP: r 2 00.95; RFP: r 2 00.94; both P <0.05) and μCT (GFP: r 2 00.86; RFP: r 2 00.86; both P<0.05) (Fig. 4a, b) . However, the tumour volumes determined by EPRI were larger, as seen by the left and up-shift of the values in Fig. 4a, b. Comparison of mean tumour volumes measured by EPRI and reconstructed MEFT compared to the reference value with US and μCT
The mean tumour volumes were almost equal for μCT (32.95±22.10 mm 3 ) and US (33.51±21.20 mm 3 ) (Fig. 5 ). The mean tumour volume for MEFT/GFP (39.63 ± 27.54 mm 3 ) was comparable to the mean volumes of US and μCT. MEFT/RFP showed a trend towards higher values with a mean tumour volume of 47.04±32.90 mm 3 ( Fig. 5 ), but they were still close to the US and μCT data. However, EPRI data with mean tumour volumes of 183.33 ± 100.65 mm 3 for GFP and of 199.14±115 mm 3 for RFP were significantly higher compared with US, μCT, MEFT and ex vivo cryoslice measurements (Fig. 5) . The maximum error for tumour size and depth determination by MEFT was low and comparable with US (<5-10 %), whereas EPRI measurements showed a high maximum error (<50 % for GFP and <40 % for RFP signal). US, μCT and MEFT gave similar results for determining the volume of subcutaneous tumours, whereas tumour volumes were significantly larger when determined by EPRI.
Correlation of tumour volume measured by reconstructed MEFT and cryoslice imaging
Imaging of ex vivo cryoslices was used as the reference method for in vivo fluorescence tomography imaging. In the present study, EPRI and MEFT data were compared with the tumour volumes that were determined by imaging ex vivo on sequential cryoslices [13] . A high correlation was found between in vivo MEFT and ex vivo cryoslice data for both GFP and RFP (GFP: r 2 00.996, P<0.05; RFP: r 2 00.999, P<0.05). The values were highly congruent with the exception of the highest value (Fig. 6a, b , dashed line marks the bisectrix at 45°). The mean tumour volumes measured on the cryoslices were also quantitatively in the range of those determined by MEFT with a trend towards higher values (cryoslice/GFP: 45.52±33.90 mm 3 ; cryoslice/RFP: 51.82± 37.24 mm 3 ; see Fig. 5 ). For ex vivo cryoslice measurements, the maximum error for tumour size determination was comparable with US and MEFT (<5-10 %).
Since the fluorescence signals in the tumour were much higher than the autofluorescence of the skin which was eliminated by thresholding, autofluorescent signals in the green channel had no influence on 3D reconstruction (Fig. 6c-e) .
Discussion
Fluorescence imaging can be performed in the reflectance geometry in the visible spectrum by detecting reflected fluorescence light using broad light excitation and appropriate filters (planar reflectance imaging). However, the penetration depth is usually limited to approximately a few millimetres because of the high photon absorption and scattering by the tissue in the visible wavelength range. In addition, planar reflectance imaging does not allow the quantitative determination of the fluorescence signal as a result of the lack of depth information. Alternatively, point . Mean value ± SD, n06; *P<0.05 for differences between EPRI data compared with the other modalities by point transillumination in fluorescence molecular tomography (FMT), using a laser with a defined wavelength for excitation in the far-red or near-infrared spectral window, allows the 3D localization and quantification of the fluorescence signals, including signals located at greater depths [14, 15] . In the transillumination geometry, the 3D reconstruction is achieved by mathematical algorithms based on diffusion approximation accounting for photon absorption and diffuse, multiple scattering in an opaque medium and air [3, 6, 16] .
An alternative approach for the 3D reconstruction of the fluorescence distribution in the reflectance geometry and quantification is MEFT. The use of powerful lasers for excitation improves the penetration depth compared with excitation by LED lamps for planar reflectance imaging. MEFT has been demonstrated to reconstruct fluorescence distributions in phantoms with high depth sensitivity of approximately 1 cm and a high accuracy. In this study, we compared non-reconstructed EPRI measurements acquired by the MEFT system and 3D reconstructed MEFT tumour volume data on subcutaneous GFP/RFP-expressing tumour xenografts in nude mice. US and μCT were used as reference methods [12] . We observed high correlation and congruency of MEFT and US as well as MEFT and μCT. MEFT also has a high correlation and congruency with ex vivo imaging of tumour cryoslices. Tumour volumes determined with EPRI also highly correlated with the values of the reference investigations; however, the tumour volumes measured by EPRI were significantly greater (4.2-to 6.0-fold). This can be explained by the strong scattering of photons in the tissue that severely hampers exact tumour demarcation. Additionally, EPRI does not acquire depth data. Using volume calculation for ellipsoids, EPRI data resulted in significantly larger volumes. By comparison, MEFT reconstructs the length, width and depth of the fluorescent object and is therefore superior in determining the tumour volume: MEFT records source-detector pairs containing distinct depthdependent information. The depth is reconstructed by algorithms that use a depth-weighted sensitivity function based on Monte Carlo simulations [7] . In addition, background images taken at different source positions are subtracted and utilized as input for the reconstruction algorithm [7] . Recent publications have demonstrated that MEFT can detect and reconstruct fluorescence signals at similar wavelengths to GFP down to a depth of 1 cm and achieved a high accuracy in determining the position (depth) and the diameter of the phantom [7, 8] . Since MEFT is based on reflectance and not on transmission, it might also have potential for quantitative endoscopic and laparoscopic applications e.g. in imageguided surgery, where transmission is (usually) not possible. The first clinical trials using fluorescent dyes or fluorescently labelled probes in image-guided surgery, e.g. fluorescent dyes like indocyanin green for real-time, radiation-free intraoperative detection of sentinel lymph nodes [17] or a folate receptor targeting probe for the intraoperative visualization of ovarian cancer cells [18] , are currently being performed.
Compared with transillumination-based tomographic systems, MEFT provides better spatial resolution. For quantifying fluorescence signals in the transillumination geometry, a larger area has to be scanned because of the high absorption and multiple scattering of the photons throughout the whole object. In MEFT, illumination and detection occur from the same side, thus the photons are scattered less intensely. As a consequence, a defined region can be scanned with a higher density of scanning spots. Thus, a higher number of more defined fluorescence areas at the surface of the object can be used for reconstruction. We suggest that the combined use of fluorescent probes targeting cancer cells and MEFT might have potential as a noninvasive technique for detecting superficial lesions, e.g. small lesions in the breast, as an alternative to intraoperative detection. Thus, MEFT may have potential as screening technology in breast cancer without radiation exposure for the patients. Cancer cell-specific fluorescent probes could also allow the highly sensitive detection of superficial lymph node metastases.
An alternative to MEFT is multi-spectral optoacoustic tomography (MSOT), which is currently in development. MSOT can reach a penetration depth of about 50-500 μm in tissues and provides an even higher resolution than MEFT. MSOT is a modified photoacoustic technology which uses photon pulses in order to generate transient fields of diffuse photons within the tissue. The absorption of photons by the optical reporter generates acoustic waves that can be detected by multiple ultrasound detectors around the sample. Measurements at multiple wavelengths allow the identification of the spectral signatures of the optical reporters. Thus, a comparison of MEFT and MSOT might be of interest with respect to size determination in fluorescent tumours.
Further studies are needed to clarify whether MEFT can also accurately detect and quantify fluorescent signals derived from tumours that are located deeper in the body. Previously, Katz et al. [19] established a highly fluorescent RFP-expressing human pancreatic cancer model, orthotopically transplanted in nude mice. A high correlation was found between image area obtained by planar reflection imaging and tumour volume measured at necroscopy (r 2 00.89). MEFT may have potential for improved imaging of fluorescent orthotopic tumours as well. Alternatively, transillumination-based tomographic systems in the far-red or near-infrared range have been applied in orthotopic models [20] . The comparison of both tomography systems for fluorescence imaging in orthotopic models will elucidate their potential (advantages) and limitations.
Current limitations of MEFT are the long total imaging time (ca. 9 min per mouse) and the long image reconstruction time of 9 min per iteration and 50-100 iterations per reconstruction. However, these issues can be improved by optimizing the reconstruction algorithm and by increasing the computer power. On the other hand, the correlation of the tumour volume data might be improved when including a higher number of animals.
In conclusion, MEFT is an innovative technique, allowing the accurate in vivo assessment of the tumour size in superficial fluorescent tumour models, and it is clearly superior to conventional planar reflectance imaging. The suitability and potential of MEFT for detecting and measuring orthotopic tumours located deeper in the tissue still have to be investigated. Besides the imaging of fluorescent cells, MEFT also has great potential for all optical imaging applications where the reflectance mode is mandatory, which is the case for most potential clinical applications.
